Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Chengdu Maxvax Biotechnology

Biotech & Life Sciences · Chengdu, China · Founded 2016 Unicorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation
$1–2.5B
Latest valuation · 2026
Unlock exact value
Revenue
$100–500M
Latest reported FY
Unlock exact value

Investors

14 investors on Chengdu Maxvax Biotechnology's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series A 3 investors entered at this stage
Hillhouse Capital
Korea Investment Partners
Sherpa Venture Partners
Series B+ 11 investors entered at this stage
Qianhai FOF
Gortune Investment
IDG Capital
Fangshizhen Capital
GF Qianhe
Sherpa Investment
Xinshang Capital
Shenzhen Capital Group
China Life Private Equity Investment
Shanghai Hankang Private Equity Fund Management
Guohai Innovative CCI Capital

Global footprint

Where Chengdu Maxvax Biotechnology has talent and traffic

Web traffic by country
130 monthly visits
across markets
🇺🇸 United States76.9%
Top 1 markets shown

See Chengdu Maxvax Biotechnology on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo